Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:49 PM
Ignite Modification Date:
2025-12-24 @ 1:49 PM
NCT ID:
NCT00981695
Eligibility Criteria:
Infant Inclusion Criteria
* Healthy infants
* \< 3 days of age (day of birth = Day 0) at enrolment
* Birth weight \> 2500 grams
* Born to an eligible woman
* Written informed consent by parent
Infant Exclusion Criteria
* HIV infection, as determined by a filter paper and/or RNA test prior to vaccination.
* Participation in any other HIV-1 vaccine or drug trial.
* Failure to receive all standard KEPI immunizations according to national immunization programme.
* Weight for age z-scores outside of 2 standard deviations of normal at the time of vaccination.
* Acute disease at the time of vaccination (acute disease is defined as the presence of a moderate or severe illness with or without fever). All vaccines can be administered to persons with a minor illness such as diarrhoea, mild upper respiratory tract infection with or without low-grade febrile illness, i.e., temperature of \<37.5 °C).
* Axillary temperature of ≥ 37.5 °C at the time of vaccination.
* Any clinically significant abnormal finding on screening from biochemistry or haematology by the time of vaccination.
* History of allergic disease or reactions likely to be exacerbated by any component of the vaccine, e.g., egg products.
* Presence of any underlying disease that compromises the diagnosis and evaluation of response to the vaccine.
* Any other on-going chronic illness requiring hospital specialist supervision.
* Administration of immunoglobulins and/or any blood products within one month preceding the planned administration of the vaccine candidate.
* Any history of anaphylaxis in reaction to vaccination.
* Research Physician's assessment of lack of willingness by parents to participate and comply with all requirements of the protocol, or identification of any factor felt to significantly increase the infant's risk of suffering an adverse outcome.
* Likelihood of travel away from the study area.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
3 Days
Study:
NCT00981695
Study Brief:
Protocol Section:
NCT00981695